It’s no secret that 2025 has been a volatile year for biotech. Venture capital has slowed dramatically over the past four years, while NIH and other funding sources face unprecedented uncertainty. Headlines about layoffs and bankruptcies are now routine.

‍

The lab space market reflects this turbulence: vacancies are climbing, landlords are struggling, and even some established incubators and shared laboratory operators are closing their doors.

‍

At Labshares, however, we’re not just weathering the storm — we’re thriving.

‍

As of Q3, Labshares is ~90% occupied across both locations. That demand reflects the strength of our model: flexible, capital-efficient, and built for the long term. Here’s how we’ve done it:

‍

1. Built for Continuity, Not Attrition

‍

Incubators are designed for short stays: they support startups through their first 12 months, then push them out to make space for the next cohort. Labshares is different.

We support companies at every stage, from early startups to publicly traded companies — some of whom have been with us for more than seven years. Our model provides the flexibility and capital efficiency of a shared lab with the professionalism and stability of a private lab.

‍

2. $15M+ in Shared Equipment – and Growing

‍

Labshares offers access to more than $15 million in cutting-edge lab equipment, all under OEM maintenance contracts and meticulously maintained. We’re the only shared lab in the region with a cell sorter, and provide access to advanced instruments like spectral flow cytometers, SPR, and automated imaging platforms.

‍

And we’re still investing: our newly upgraded tissue culture and lentiviral suite is now open, and more equipment is on the way.

‍

3. Financial Flexibility

‍

Our members benefit from a single, all-inclusive rate that covers lab space, office space, equipment access, and staff support. No hidden fees. No equity. No surprises. Just predictable, transparent pricing. And unlike leases or subleases, our contract terms are shorter and designed to better match the timelines of biotech.

‍

4. Scalable Space That Grows with You

‍

Labshares makes it easy to scale without costly build-outs or operational disruption. From individual benches to private suites for up to 30 scientists, our flexible contracts allow you to adjust your lab as your needs evolve — whether you’re ramping up after a funding round or consolidating following a strategic pivot.

‍

5. Operational Support That Feels In-House

‍

From safety and permitting to equipment uptime and waste management, our on-site team handles it all. 99%+ equipment uptime and real-time resolution support mean scientists can stay focused on hitting milestones. Surveys confirm a 100% satisfaction rate among our members.

‍

6. Our Financial Strength

‍

Amid headlines of shared labs in Boston facing financial strain, we want to be clear about Labshares’ position:

• Labshares is financially strong, with nearly 90% occupancy, stable cash flows, and no liquidity or lease concerns.
• We continue to invest in best-in-class equipment and facilities while maintaining a conservative and resilient capital strategy.
• Our 2026 expansion plans are moving forward — a clear signal of both our stability and our optimism about the future of biotech.

‍

Looking Ahead:

‍

At a time when uncertainty is reshaping the lab space landscape, Labshares continues to offer stability, transparency, and a proven model that supports biotechs at every stage. Whether you’re just getting started or streamlining your operations, Labshares provides a flexible, capital-efficient way to advance your science.

‍

‍